TMB cut-offs fail to predict benefit of PD-1 blockade in gastroesophageal adenocarcinoma in KEYNOTE-061
| Errataetall: |
CommentIn: Ann Oncol. 2021 Oct;32(10):1303-1304. - PMID 34242742 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Annals of oncology : official journal of the European Society for Medical Oncology - 32(2021), 9 vom: 01. Sept., Seite 1188-1189 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Foote, M B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
B7-H1 Antigen |
|---|
| Anmerkungen: |
Date Completed 03.09.2021 Date Revised 16.07.2022 published: Print-Electronic CommentIn: Ann Oncol. 2021 Oct;32(10):1303-1304. - PMID 34242742 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.annonc.2021.06.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326868127 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326868127 | ||
| 003 | DE-627 | ||
| 005 | 20231225195525.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.annonc.2021.06.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1089.xml |
| 035 | |a (DE-627)NLM326868127 | ||
| 035 | |a (NLM)34139271 | ||
| 035 | |a (PII)S0923-7534(21)02054-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Foote, M B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a TMB cut-offs fail to predict benefit of PD-1 blockade in gastroesophageal adenocarcinoma in KEYNOTE-061 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.09.2021 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Ann Oncol. 2021 Oct;32(10):1303-1304. - PMID 34242742 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a B7-H1 Antigen |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 650 | 7 | |a Programmed Cell Death 1 Receptor |2 NLM | |
| 700 | 1 | |a Maron, S B |e verfasserin |4 aut | |
| 700 | 1 | |a Cercek, A |e verfasserin |4 aut | |
| 700 | 1 | |a Argilés, G |e verfasserin |4 aut | |
| 700 | 1 | |a Rousseau, B |e verfasserin |4 aut | |
| 700 | 1 | |a Diaz, L A |c Jr |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology : official journal of the European Society for Medical Oncology |d 1990 |g 32(2021), 9 vom: 01. Sept., Seite 1188-1189 |w (DE-627)NLM012606308 |x 1569-8041 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2021 |g number:9 |g day:01 |g month:09 |g pages:1188-1189 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.annonc.2021.06.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2021 |e 9 |b 01 |c 09 |h 1188-1189 | ||